Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

When is data "practice-changing"? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time? All that and more on the latest…

When is data “practice-changing”? How many Covid-19 vaccines do we need? And what does it mean when the FDA asks for more time?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With the world’s largest cancer conference just concluded, we explain the most important data presented at the meeting, including a blockbuster clinical trial that promises to change the treatment of advanced breast cancer. We also discuss an FDA controversy in the making, a pair of new Covid-19 vaccines, and the frustrating process of finding new treatments for depression.

Read the rest…